MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-08-0007369
Biodeal Pharmaceuticals Limited - pharma in Solan (Hp), Himachal Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹209.4 Cr
▲ 46% YoY
Net profit · FY 2025
₹15.18 Cr
Net margin 7.2%
EBITDA · FY 2025
₹45.28 Cr
EBITDA margin 21.6%
Authorised capital
₹25.45 Cr
Registered with MCA
Paid-up capital
₹25.34 Cr
Issued & subscribed
Open charges
₹212.08 Cr
Satisfied ₹122.92 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
343
Provident fund records
About Biodeal Pharmaceuticals Limited
Data last updated:
Biodeal Pharmaceuticals Limited is a public limited company based in Solan (Hp), Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 December 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U00304HP2005PLC029451. Its GSTIN is 02AACCB8125A1ZH (Himachal Pradesh). The company holds 6 GST registrations, all of them active.
The company has an authorised share capital of ₹25.45 Cr and a paid-up capital of ₹25.34 Cr. It is led by directors including Anurag Kumar (Managing Director) and Dev Datt.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Village Saini Majra Nalagarh – Ropar Road Teh. Nalagarh Distt. Solan (Hp)., Himachal Pradesh, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹209.4 Cr, a growth of 46% compared to the previous year. For the same year it recorded a net profit of ₹15.18 Cr (net margin 7.2%) and EBITDA of ₹45.28 Cr (EBITDA margin 21.6%). Revenue has grown at a compounded annual rate (CAGR) of 43% over three years and 32% over five years.
The company has about 343 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Biodeal Pharmaceuticals. As per MCA filings, the company has open charges of ₹212.08 Cr and satisfied charges of ₹122.92 Cr on record. Court records list 22 cases involving the company, including 6 filed by the company and 16 filed against it; 14 cases are pending. The company has 12 deals on record (7 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹136.01 Cr; the latest was in March 2024. Its 7 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is Speciality Organics Pvt Ltd with revenue of ₹214.1 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 206 overdue payments to 38 micro and small suppliers.
Biodeal Pharmaceuticals Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0007369). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biodealpharma.com.
Company details
CIN U00304HP2005PLC029451
Registration Number 029451
Incorporation Date 30 December 2005
ROC Himachal Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DL-08-0007369
CIN history
Biodeal Pharmaceuticals has one previous CIN (Corporate Identification Number): U00304HP2005PTC029451. The current CIN is U00304HP2005PLC029451, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U00304HP2005PLC029451 | Current |
| U00304HP2005PTC029451 | Previous |
Recognitions & Rankings of Biodeal Pharmaceuticals
Contact details
Biodeal Pharmaceuticals Limited's registered office is in Solan (Hp), Himachal Pradesh. Its website is biodealpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressVillage Saini Majra Nalagarh – Ropar Road Teh. Nalagarh Distt. Solan (Hp)., Himachal Pradesh, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Biodeal Pharmaceuticals Limited, buy the company report.
Comprehensive company report
Biodeal Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Biodeal Pharmaceuticals operates one associated brand: Biodeal Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations are manufactured by Biodeal Pharmaceuticals in Delhi. | biodealpharma.com |
Business activity
The main business activities of Biodeal Pharmaceuticals are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Biodeal Pharmaceuticals Limited, buy the company report.
Financials of Biodeal Pharmaceuticals Limited
FY 2025 filings availableBiodeal Pharmaceuticals Limited reported revenue of ₹209.4 Cr (up 46% YoY) for FY 2025.
Revenue · FY 2025
₹209.4 Cr ▲ 46%
Net profit · FY 2025
₹15.18 Cr margin 7.2%
EBITDA · FY 2025
₹45.28 Cr margin 21.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 46%
3 years · compounded
▲ 43%
5 years · compounded
▲ 32%
EBITDA CAGR growth
1 year
▲ 64%
3 years · compounded
▲ 56%
5 years · compounded
▲ 46%
Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 46% growth in the latest year. EBITDA rose 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹45.28 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.18 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.6% | ||||
| Net Profit Margin | 7.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biodeal Pharmaceuticals Limited, buy the company report.
Board of directors of Biodeal Pharmaceuticals Limited
Biodeal Pharmaceuticals has 6 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dev Datt | Director | 01 Apr 2021 | 5 Years 6 Months | Current |
| Anurag Kumar | Managing Director | 31 Dec 2020 | 5 Years 9 Months | Current |
| Anchal Kumari | Director | 30 Nov 2022 | 3 Years 10 Months | Current |
| Noopur Jha | Director | 14 Jun 2024 | 2 Years 4 Months | Current |
| Abhishek Jain Also directs: Harmony Organics Private Limited, Saimirra Innopharm Private Limited, 3 Gen Consulting Services Private Limited and 1 more | Nominee Director | 16 May 2025 | 1 Years 5 Months | Current |
| Adheesh Chander Malhotra | Additional Director | 20 Jun 2025 | 1 Years 4 Months | Current |
Peer comparison
Biodeal Pharmaceuticals Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Speciality Organics Pvt Ltd | ₹214.1 Cr (FY 2025) | 34.0% | Mandideep, Madhya Pradesh, India | |||
| Vins Bioproducts Limited | ₹210.48 Cr (FY 2025) | 34.0% | Maheswaram, Telangana, India | |||
| Kilitch Drugs (India) Limited. | ₹209.48 Cr (FY 2025) | 32.0% | Thane, Maharashtra, India | |||
| Biodeal Pharmaceuticals Limitedthis company | ₹209.4 Cr (FY 2025) | ₹15.18 Cr | 7.2% | 46.0% | 343 | Solan (Hp), Himachal Pradesh, India |
| Cheryl Laboratories Pvt Ltd | ₹206.58 Cr (FY 2025) | 14.0% | Mumbai, Maharashtra, India | |||
| Smilax Laboratories Limited | ₹206.57 Cr (FY 2025) | -25.0% | Hyderabad, Telangana, India | |||
| Radison Labs Private Limited | ₹202.11 Cr (FY 2025) | 43.0% | Hyderabad, Telangana, India | |||
| Topnotch Chemicals Pvt Ltd | ₹201.92 Cr (FY 2024) | -14.0% | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Biodeal Pharmaceuticals Limited, buy the company report.
Auditor
Biodeal Pharmaceuticals Limited is audited by Khandelwal Jain & Co (Chartered Accountants) for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Khandelwal Jain & Co (Chartered Accountants) | FY 2024 | 105049W |
Shareholding
The shareholding of Biodeal Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Biodeal Pharmaceuticals Limited, buy the company report.
Charges & borrowings
Open charges
₹212.08 Cr
Satisfied charges
₹122.92 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Oct 2025 | 101182326 | Axis Bank Limited | ₹50 Cr | Open | |
| 25 Sep 2025 | 101188927 | Hdfc Bank Limited | ₹1.31 Cr | Open | |
| 29 Aug 2025 | 101167590 | Hdfc Bank Limited | ₹31.4 Lakh | Open | |
| 06 May 2025 | 101117389 | Hdfc Bank Limited | ₹11.42 Lakh | Open | |
| 21 Feb 2025 | 101076654 | Hdfc Bank Limited | ₹24.63 Lakh | Open |
To see the full charge records of Biodeal Pharmaceuticals Limited, buy the company report.
Total charge records: 28 View all charges
Deals & funding
Biodeal Pharmaceuticals Limited has 12 deals on record (7 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹136.01 Cr; the latest was in March 2024.
Total deals
12
Secondary share transfers
7
Funding rounds
3
Rights issue
1
Convertible or debt financing
1
Disclosed funding
₹136.01 Cr
Deals on record (5 of 12)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2023 | Rights issue | ₹1.02 Cr | Investors: an individual |
| Dec 2022 | Funding round | ₹1.02 Cr | Investors: an individual |
| Dec 2022 | Secondary share transfer | Undisclosed | Buyer: Pradeep Kumar Jajodia Huf, 3 individuals Seller: an individual |
| Apr 2016 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Biodeal Pharmaceuticals Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Biodeal Pharmaceuticals Limited has 22 court cases on record: 6 filed by Biodeal Pharmaceuticals, 16 filed against it. 14 cases are pending and 8 are disposed.
Total cases
22
Filed by the company
6
Filed against the company
16
Pending
14
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 19 | 13 | 13 |
| High courts | 3 | 3 | 1 |
Cases on record (5 of 22)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (CRR) | Filed against the company by Glenmark Pharmaceuticals Ltd | Pending |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Meteoric Biopharmaceuticals Pvt Ltd - Kirankumar Patel | Pending |
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed by the company against Fenway Pharmaceuticals Pvt. Ltd. and 2 others | Pending |
| Bombay High Court | Court case (COMIP) | Filed against the company by Hindustan Unilever Limited | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Hindustan Unilever Limited | Disposed |
To see the full case history of Biodeal Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Biodeal Pharmaceuticals Limited was last rated by Care on 21 Sep 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 21 Sep 2022 |
To see the full credit ratings and regulatory alerts of Biodeal Pharmaceuticals Limited, buy the company report.
MSME payment delays
Biodeal Pharmaceuticals Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 206 overdue payments to 38 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 38)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Meteoric Biopharmaceuticals Private Limited | |||
| an individual supplier | |||
| Fido Pharma Private Limited | |||
| Radhashok Pharmachem Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Biodeal Pharmaceuticals Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Biodeal Pharmaceuticals Limited has a workforce of 343 employees on its EPFO records as of Apr 10, 2025, across 1 active EPFO establishment.
Employee count
343
Active EPFO establishments
1
Employee growth
20.77%
GST
Biodeal Pharmaceuticals has 6 GST registrations: 6 active. The first 4 active GSTINs are listed below.
Total GSTINs
6
Active
6
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AACCB8125A1ZH | Himachal Pradesh | Active | 01 Jul 2017 |
| 07AACCB8125A1Z7 | Delhi | Active | 27 Dec 2017 |
| 36AACCB8125A1Z6 | Telangana | Active | 26 Apr 2022 |
| 08AACCB8125A1Z5 | Rajasthan | Active | 23 Feb 2023 |
To see the full GST registrations and return filing status of Biodeal Pharmaceuticals Limited, buy the company report.
Recent activity
Biodeal Pharmaceuticals Limited has 18 board changes on record since 2016: 8 appointments and 10 cessations. The latest: Adheesh Chander Malhotra was appointed as Additional Director on 20 Jun 2025.
Charges
A charge registered on 18 Jan 2022 via Charge ID 100527051 with Sidbi was fully satisfied on 20 Nov 2025.
Charges
A charge with Axis Bank Limited amounted to Rs. 50.00 Cr with Charge ID 101182326 was registered on 18 Oct 2025.
AGM
Biodeal Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.31 Cr with Charge ID 101188927 was registered on 25 Sep 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.31 Cr with Charge ID 101167590 was registered on 29 Aug 2025.
Charges
A charge with Yes Bank Limited of Rs. 50.00 Cr registered on 21 Aug 2023 with Charge ID 100764514 was modified on 29 Jul 2025.
Appointed
Adheesh Chander Malhotra was appointed as Additional Director.
Appointed
Abhishek Jain was appointed as Nominee Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.11 Cr with Charge ID 101117389 was registered on 06 May 2025.
Ceased
Gurudutta Mishra ceased to be Nominee Director.
Filing
Biodeal Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Himachal Pradesh.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.25 Cr with Charge ID 101076654 was registered on 21 Feb 2025.
70 earlier events are in the company report.
Frequently asked questions
Biodeal Pharmaceuticals is an active public limited company based in Solan (Hp), Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 December 2005 (21+ years old) and is registered under CIN U00304HP2005PLC029451.
Biodeal Pharmaceuticals has 6 current directors:
- Anurag Kumar - Managing Director
- Dev Datt - Director
- Anchal Kumari - Director
- Noopur Jha - Director
- Abhishek Jain - Nominee Director
- Adheesh Chander Malhotra - Additional Director
The latest financial statements of Biodeal Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Biodeal Pharmaceuticals is 02AACCB8125A1ZH, registered in Himachal Pradesh. The company has 6 GST registrations in all, of which 6 are active. Other active GSTINs include 07AACCB8125A1Z7 (Delhi), 36AACCB8125A1Z6 (Telangana), 08AACCB8125A1Z5 (Rajasthan).
The CIN (Corporate Identification Number) of Biodeal Pharmaceuticals is U00304HP2005PLC029451. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biodeal Pharmaceuticals has 22 court cases on record: 6 filed by the company and 16 filed against it. 14 are pending. Most are in the district courts.
Biodeal Pharmaceuticals was incorporated on 30 December 2005, making it 21+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
Biodeal Pharmaceuticals has 12 deals on record (7 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹136.01 Cr; the latest was in March 2024.
The peers of Biodeal Pharmaceuticals by revenue are Speciality Organics Pvt Ltd, Vins Bioproducts Limited, Kilitch Drugs (India) Limited, Cheryl Laboratories Pvt Ltd, Smilax Laboratories Limited and 2 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Adheesh Chander Malhotra was appointed as Additional Director on 20 Jun 2025. Abhishek Jain was appointed as Nominee Director on 16 May 2025. Gurudutta Mishra ceased to be Nominee Director on 24 Apr 2025. Biodeal Pharmaceuticals has 18 board changes on record in total.
Yes, Biodeal Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-08-0007369).
Biodeal Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 206 overdue payments to 38 micro and small suppliers. The latest return was filed on 30 Apr 2024.